Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Entegris Inc (ENTG) vs FMC Corp (FMC) Price & Performance

Entegris IncTrade
FMC CorpTrade

Price performance (Past 24H)

Key statistics

Entegris Inc vs FMC Corp — how do they compare? Entegris Inc trades at $132.96 (market cap $21.12B), while FMC Corp trades at $11.4 (market cap $1.36B). The key difference: Entegris Inc is far larger — about 15.5× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.

ENTGFMC
Market Cap
$21.12B$1.36B
Sector
TechnologyBasic Materials
52-Week High
$184.00$43.90
52-Week Low
$68.80$10.72
Enterprise Value
$24.44B$5.50B
Dividend Yield
0.29%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Entegris Inc

ENTG trades at $134.15, down 4.61% today, with technical indicators showing bearish momentum as the stock approaches key support at $133. The company maintains solid fundamentals with Q1 2026 earnings beating estimates at $0.86 per share and strong analyst consensus of 65% buy ratings. Recent developments include a $0.10 dividend declaration and new CFO appointment, while semiconductor industry tailwinds from AI-driven demand provide growth catalysts.

ENTG presents a compelling opportunity with 25% upside to the $178.40 consensus price target, supported by improving cash flow trends and semiconductor sector growth. However, elevated valuation multiples (P/E 80.17) and technical bearish signals warrant caution amid recent price volatility and competitive pressures in the semiconductor materials space.

FMC Corp

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Returns comparison

Trailing returns across standard periods

About Entegris Inc

Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.

Read more on ENTG

About FMC Corp

FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.

Read more on FMC